Clinical Trials Logo

Crow's Feet Lines clinical trials

View clinical trials related to Crow's Feet Lines.

Filter by:

NCT ID: NCT06402058 Not yet recruiting - Crow's Feet Lines Clinical Trials

A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement

Start date: June 10, 2024
Phase: N/A
Study type: Interventional

The objective of this Pilot Study is to verify the safety and efficacy of DMSB01 in the temporary improvement of Crow's Feet Lines

NCT ID: NCT06376838 Completed - Crow's Feet Lines Clinical Trials

To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet

dermal filler
Start date: July 7, 2020
Phase: N/A
Study type: Interventional

This clinical study is a confirmatory clinical study to prove that the test device, DLMR01, is non-inferior to the control device, Rejuran®, in terms of temporary wrinkle improvement effect on crow's feet and safety. After applying DLMR01, a test device, and Rejuran®, a control device, respectively to wrinkles around the eyes, randomization to compare and evaluate the temporary wrinkle improvement effect and safety of the two clinical study medical devices, subject-evaluator blinding, pair matching, It was designed as a comparative clinical study.

NCT ID: NCT04081402 Recruiting - Crow's Feet Lines Clinical Trials

A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines

Start date: November 1, 2018
Phase: Phase 3
Study type: Interventional

A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines

NCT ID: NCT03408236 Completed - Crow's Feet Lines Clinical Trials

Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines

Start date: January 17, 2018
Phase: Phase 3
Study type: Interventional

To determine the efficacy and safety of Botulax® in treatment of crow's feet line

NCT ID: NCT03317574 Completed - Crow's Feet Lines Clinical Trials

MEDITOXIN® in Treatment of Crow's Feet Line

Start date: August 17, 2017
Phase: Phase 3
Study type: Interventional

to determine the efficacy and safety of Meditoxin® in treatment of crow's feet line

NCT ID: NCT03184363 Not yet recruiting - Glabellar Lines Clinical Trials

Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)

Start date: July 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to explore the Efficacy and Safety of DWP450 for treating Crows Feet Lines(CFL) in combination with glabellar line(GL) as extension study of phase 3 study for CFL.

NCT ID: NCT02248844 Completed - Clinical trials for Lateral Canthal Lines

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Start date: September 26, 2014
Phase:
Study type: Observational

This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.

NCT ID: NCT02195687 Completed - Clinical trials for Lateral Canthal Lines

BOTOX® in the Treatment of Crow's Feet Lines in China

Start date: September 2014
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) compared with placebo in patients with moderate to severe crow's feet lines (lateral canthal lines).

NCT ID: NCT02176356 Completed - Glabellar Lines Clinical Trials

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

Start date: June 30, 2014
Phase: Phase 4
Study type: Interventional

A study to evaluate patient satisfaction, aesthetic and psychological impact of combined treatment with BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS XC, JUVÉDERM® VOLUMA® XC, and LATISSE® (bimatoprost ophthalmic solution).

NCT ID: NCT01797094 Completed - Glabellar Lines Clinical Trials

BOTOX® in the Treatment of Upper Facial Lines in Japan

Start date: February 2013
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) for the treatment of upper facial lines (Crow's Feet Lines and Frown Lines).